CD8A and neoplasm: Our findings that tumor infiltrating bystander CD8 T cells do not exhibit hallmarks of exhaustion, such as sustained inhibitory receptor expression, loss of cytokine production (4) and terminal differentiation (59), bear implications for future exploitation of bystander tumor-resident memory T cells for indirect augmentation of tumor-reactive T cells during checkpoint blockade immunotherapy as suggested by Rosato et al.